Australia's largest stock trading and investment forum Australia's #1 stock forum

SP1

Click for more information

0.00%

$1.07 southern cross payments ltd

settle down there. Lets not get too excited. you can put US$2000...

First 29 Last

Share
Profile

Follow
kemenya

436 Posts.

09/07/16

07:54

Post #: 18230580
Share

Originally posted by hero of xerox ↑

Revenue is the key...but we're now getting announcements with some clarity on the volumes involved.

XM have 500,000 existing clients
Tradologic have 1,500,000 and over 900m transactions annually.

It's possible XM and Tradologic require ISX process to KYC the existing clients making them current and compliant with new regulations.

So for these 2 clients alone we have a potential:

2,000,000 @ $10.00 (assumed upfront KYC price) = $20,000,000 upfront
1.2 billion transactions annually (assuming 300 million XM transactions...could be more) @ 0.03 per transaction (again assumed price) = $36,000,000 per annum.

The figures per transaction here are purely speculative...but they help provide some indication on revenue potential.

If ISX keeps signing clients these types of clients...well you can guess what the revenue will look like.

What valuation do you put on a tech company with $100 - 200 mil EBIT? 10 - 15x I would think!!!

Have a good weekend all and DYOR

Expand

settle down there. Lets not get too excited.

you can put US$2000 into a FX account and churn it thousands of times. That means one cash transaction has occurred. Basing your revenue numbers on each fx trade is so weong that we shouldn't even discuss it, or base 'speculative'numbers on it.

ISX Price at posting: 24.0¢ Sentiment: Hold Disclosure: Not Held
5 Upvote

0 Great analysis

Reply

Top Stories

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

HotCopper Highlights: Your most watched stocks for Week 46, 2024

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

First 29 Last

Add SP1 (ASX) to my watchlist

SPONSORED BY